Skip to main content
Erschienen in: Clinical Rheumatology 11/2022

11.07.2022 | Original Article

High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies

verfasst von: Aline Marques Caetano, Isabela Bruna Pires Borges, Lila Morena Bueno da Silva, Samuel Katsuyuki Shinjo

Erschienen in: Clinical Rheumatology | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction/objectives

This study aimed to analyze the presence, grade, and relevance of myofiber necrosis in the muscle tissues of patients with adult dermatomyositis. Second, these parameters were associated with the patients’ demographic, clinical, and laboratory data.

Method

This was a retrospective study, from 2001 to 2021, which included 89 muscle biopsies of patients with definite dermatomyositis performed at the time of diagnostic investigation. Immunohistochemical analysis was performed on serially frozen muscle sections. The presence and degree of endomysial/perifascicular myofiber necrosis were also analyzed. The degree of necrosis was semi-quantitatively coded as absent/mild, moderate, or severe. The presence or absence of perifascicular atrophy and also perivascular lymphomononuclear infiltration was also evaluated.

Results

Muscle biopsies from 89 patients, the majority of whom were Caucasian women, were evaluated. Both perifascicular atrophy and perivascular lymphomononuclear infiltrates were observed in 76 (85.4%) samples. Moderate or intense areas of myofiber necrosis in endomysial/perifascicular areas were found in 30/89 (33.7%) and 14/89 (15.7%) muscle biopsies, respectively, with a predominance of macrophagic infiltrate in relation to lymphomononuclear cells in these regions. The degree of muscle weakness in the limbs (upper and lower) was associated only with areas of intense myofiber necrosis.

Conclusions

A high prevalence of myofiber necrosis was observed, which patients resembled the initial clinical feature of patients with immune-mediated necrotizing myopathies.
Key Point
A high prevalence of myofiber necrosis was observed in muscle biopsies of patients with dermatomyositis
Literatur
1.
Zurück zum Zitat Dalakas MC (2015) Inflammatory muscle diseases, Review. N Engl J Med 372:1734–1747CrossRef Dalakas MC (2015) Inflammatory muscle diseases, Review. N Engl J Med 372:1734–1747CrossRef
2.
Zurück zum Zitat Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L et al (2017) EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 69:2271–2282CrossRef Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L et al (2017) EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 69:2271–2282CrossRef
3.
Zurück zum Zitat Muro Y, Sugiura K, Akiyama M (2016) Cutaneous manifestations in dermatomyositis: key clinical and serological features - a comprehensive review. Clin Rev Allergy Immunol 51:293–302CrossRef Muro Y, Sugiura K, Akiyama M (2016) Cutaneous manifestations in dermatomyositis: key clinical and serological features - a comprehensive review. Clin Rev Allergy Immunol 51:293–302CrossRef
4.
Zurück zum Zitat De Souza FHC, De Araújo DB, Vilela VS, Simões RS, Bernardo WM, Fran TA, Da Cunha BM et al (2019) The Brazilian Society of Rheumatology recommendations on investigation and diagnosis of systemic autoimmune myopathies. Adv Rheumatol 15:42CrossRef De Souza FHC, De Araújo DB, Vilela VS, Simões RS, Bernardo WM, Fran TA, Da Cunha BM et al (2019) The Brazilian Society of Rheumatology recommendations on investigation and diagnosis of systemic autoimmune myopathies. Adv Rheumatol 15:42CrossRef
5.
Zurück zum Zitat Pallo PAO, Silva MSR, De Souza FHC, Shinjo SK (2020) Is polymyositis a rare or over-diagnosed entity? A descriptive follow-up study of patients initially admitted in a tertiary center with the diagnosis of polymyositis. Indian J Rheumatol 15:180–186CrossRef Pallo PAO, Silva MSR, De Souza FHC, Shinjo SK (2020) Is polymyositis a rare or over-diagnosed entity? A descriptive follow-up study of patients initially admitted in a tertiary center with the diagnosis of polymyositis. Indian J Rheumatol 15:180–186CrossRef
6.
Zurück zum Zitat Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. Pt I N Engl J Med 292:344–347CrossRef Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. Pt I N Engl J Med 292:344–347CrossRef
7.
Zurück zum Zitat Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. Pt II N Engl J Med 292:403–407CrossRef Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. Pt II N Engl J Med 292:403–407CrossRef
8.
Zurück zum Zitat Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971–982CrossRef Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971–982CrossRef
9.
Zurück zum Zitat Dalakas MC (2002) Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 28:779–798CrossRef Dalakas MC (2002) Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 28:779–798CrossRef
10.
Zurück zum Zitat Tanboon J, Inoue M, Hirakawa S, Tachimori H, Hayashi S, Noguchi S, Suzuki S et al (2022) Dermatomyositis: muscle pathology according to antibody subtypes. Neurology 98:e739–e749CrossRef Tanboon J, Inoue M, Hirakawa S, Tachimori H, Hayashi S, Noguchi S, Suzuki S et al (2022) Dermatomyositis: muscle pathology according to antibody subtypes. Neurology 98:e739–e749CrossRef
11.
Zurück zum Zitat Mammen A L, Allenbach Y, Stenzel W, Benveniste O, ENMC 239th Workshop Study Group (2020) 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands. Neuromuscul Dis 30:70–92 Mammen A L, Allenbach Y, Stenzel W, Benveniste O, ENMC 239th Workshop Study Group (2020) 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands. Neuromuscul Dis 30:70–92
12.
Zurück zum Zitat Tanboon J, Inoue M, Hirakawa S, Tachimori H, Hayashi S, Noguchi S, Nishino I (2021) Pathological features of anti-Mi-2 dermatomyositis. Neurology 96:e488–e459CrossRef Tanboon J, Inoue M, Hirakawa S, Tachimori H, Hayashi S, Noguchi S, Nishino I (2021) Pathological features of anti-Mi-2 dermatomyositis. Neurology 96:e488–e459CrossRef
13.
Zurück zum Zitat Pinal-Fernandez I, Mecoli CA, Casal-Dominguez M, Pak K, Hosono Y, Huapaya J, Huang W et al (2019) More prominent muscle involvement in patients with dermatomyositis with anti-Mi-2 autoantibodies. Neurology 93:e1768–e1777CrossRef Pinal-Fernandez I, Mecoli CA, Casal-Dominguez M, Pak K, Hosono Y, Huapaya J, Huang W et al (2019) More prominent muscle involvement in patients with dermatomyositis with anti-Mi-2 autoantibodies. Neurology 93:e1768–e1777CrossRef
14.
Zurück zum Zitat Fornaro M, Girolamo F, Cavagna L, Franceschini F, Giannini M, Amati A, Lia A et al (2021) Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi-2 positive dermatomyositis. Rheumatology (Oxford) 60:2916–2926CrossRef Fornaro M, Girolamo F, Cavagna L, Franceschini F, Giannini M, Amati A, Lia A et al (2021) Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi-2 positive dermatomyositis. Rheumatology (Oxford) 60:2916–2926CrossRef
15.
Zurück zum Zitat Cruellas MGP, Viana VST, Levy-Neto M, Souza FHC, Shinjo SK (2013) Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics 68:909–914CrossRef Cruellas MGP, Viana VST, Levy-Neto M, Souza FHC, Shinjo SK (2013) Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics 68:909–914CrossRef
16.
Zurück zum Zitat Schlecht N, Sunderkötter C, Niehaus S, Nashan D (2020) Update on dermatomyositis in adults. J Dtsch Dermatol Ges 18:995–1014PubMed Schlecht N, Sunderkötter C, Niehaus S, Nashan D (2020) Update on dermatomyositis in adults. J Dtsch Dermatol Ges 18:995–1014PubMed
17.
Zurück zum Zitat Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100CrossRef Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100CrossRef
18.
Zurück zum Zitat Hou Y, Shao K, Yan Y, Dai T, Li W, Zhao Y, Li D, Lu JQ, Norman GL, Yan C (2022) Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy. J Neurol 269:280–293CrossRef Hou Y, Shao K, Yan Y, Dai T, Li W, Zhao Y, Li D, Lu JQ, Norman GL, Yan C (2022) Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy. J Neurol 269:280–293CrossRef
19.
Zurück zum Zitat Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D et al (2018) Statin-naive anti-HMGCR antibody-mediated necrotizing myopathy in China. J Clin Neurosci 57:13–19CrossRef Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D et al (2018) Statin-naive anti-HMGCR antibody-mediated necrotizing myopathy in China. J Clin Neurosci 57:13–19CrossRef
20.
Zurück zum Zitat Alshehri A, Choksi R, Bucelli R, Pestronk A (2015) Myopathy with anti-HMGCR antibodies: perimysium and myofiber pathology. Neurol Neuroimmunol Neuroinflamm 2:e124CrossRef Alshehri A, Choksi R, Bucelli R, Pestronk A (2015) Myopathy with anti-HMGCR antibodies: perimysium and myofiber pathology. Neurol Neuroimmunol Neuroinflamm 2:e124CrossRef
21.
Zurück zum Zitat Authier FJ, Kondo H, Ghnassia RT, Revuz J, Gherardi RK (1996) Necrotizing myopathy with pipestem capillaries and minimal cellular infiltration: a case associated with cutaneous signs of dermatomyositis. Neurology 46:1448–1451CrossRef Authier FJ, Kondo H, Ghnassia RT, Revuz J, Gherardi RK (1996) Necrotizing myopathy with pipestem capillaries and minimal cellular infiltration: a case associated with cutaneous signs of dermatomyositis. Neurology 46:1448–1451CrossRef
22.
Zurück zum Zitat Climent-Albaladejo A, Saiz-Cuenca E, Rosique-Roman J, Caballero-Rodriguez J, Galvez-Munoz J (2002) Dermatomyositis sine myositis and antisynthetase syndrome. Jt Bone Spine 69:72–75CrossRef Climent-Albaladejo A, Saiz-Cuenca E, Rosique-Roman J, Caballero-Rodriguez J, Galvez-Munoz J (2002) Dermatomyositis sine myositis and antisynthetase syndrome. Jt Bone Spine 69:72–75CrossRef
23.
Zurück zum Zitat Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Mammen AL (2010) A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 62:2757–2766CrossRef Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Mammen AL (2010) A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 62:2757–2766CrossRef
24.
Zurück zum Zitat Wedderburn LR, Varsani H, Li CK, Newton KR, Amato AA, Banwell B, Bove KE et al (2007) International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 57:1192–1201CrossRef Wedderburn LR, Varsani H, Li CK, Newton KR, Amato AA, Banwell B, Bove KE et al (2007) International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 57:1192–1201CrossRef
25.
Zurück zum Zitat Pinal-Fernandez I, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL (2015) The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis. J Rheumatol 42:1448–1454CrossRef Pinal-Fernandez I, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL (2015) The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis. J Rheumatol 42:1448–1454CrossRef
Metadaten
Titel
High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
verfasst von
Aline Marques Caetano
Isabela Bruna Pires Borges
Lila Morena Bueno da Silva
Samuel Katsuyuki Shinjo
Publikationsdatum
11.07.2022
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 11/2022
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-022-06270-4

Weitere Artikel der Ausgabe 11/2022

Clinical Rheumatology 11/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.